Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial

INTRODUCTION: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has become standard of care for patients with peritoneal metastases of colorectal origin with a low/moderate abdominal disease load. In case of a peritoneal cancer index (PCI) score >20, CRS-HIPEC is not...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: de Boer, Nadine Leonie, Brandt-Kerkhof, Alexandra R M, Madsen, Eva V E, Diepeveen, Marjolein, van Meerten, Esther, van Eerden, Ruben A G, de Man, Femke M, Bouamar, Rachida, Koolen, Stijn L W, de Hingh, Ignace H J T, Bakkers, Checca, Rovers, Koen P, Creemers, Geert-Jan M, Deenen, Maarten J, Kranenburg, Onno W, Constantinides, Alexander, Mathijssen, Ron H J, Verhoef, Cornelis, Burger, Jacobus W A
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6924694/
https://ncbi.nlm.nih.gov/pubmed/31818845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-034508
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados